Normalisation of circulating neutrophil counts after 12 months of elexacaftor-tezacaftor-ivacaftor in patients with advanced cystic fibrosis

The European respiratory journal(2023)

引用 6|浏览8
暂无评分
摘要
In people with cystic fibrosis and advanced lung disease, circulating neutrophils were often elevated under clinically stable conditions. Treatment with elexacaftor-tezacaftor-ivacaftor for 12 months is associated with normalisation of neutrophil counts. http://bit.ly/3gtgDFx
更多
查看译文
关键词
advanced cystic fibrosis,neutrophil counts,cystic fibrosis,elexacaftor-tezacaftor-ivacaftor
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要